Germany�s Bayer to buy U.S. gene therapy specialist AskBio
Update: 2025-10-09
Description
The German health care company Bayer said it�s buying Asklepios BioPharmaceutical, a U.S.-based firm specializing in gene therapy, in a deal worth up to $4 billion.Bayer says it�ll lead to cell and gene therapy platforms that could prevent or even cure diseases caused by gene defects.?Bayer said....
This item belongs to: audio/rivet360-audio-collection.
This item has files of the following types: Archive BitTorrent, Columbia Peaks, Item Tile, Metadata, PNG, Spectrogram, VBR MP3
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
